Caribou Biosciences
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $138M
Investors
- 24
About Caribou Biosciences
Based in California, US, Caribou Biosciences Inc. was founded in 2011 by co-founders James Berger, Jennifer A. Doudna, Martin Jinek, and Rachel E. Haurwitz. The company is a clinical-stage CRISPR genome editing biotechnology company that creates a clinical-stage therapeutic and a pipeline of pre-clinical allogeneic CAR-T and CAR-NK cell therapies that are potentially transformative for patients. In July 2021, the company became a public company and got listed under the ticker symbol CRBU. As of July 2021, the company has 66 employees. Caribou Biosciences provides two fundamental components of CRISPR systems: the nuclease protein(s) that cut DNA and the RNA molecule(s) that direct the nuclease to create a site-specific, double-stranded break, resulting in editing at the targeted genomic location. Caribou Biosciences created chRDNAs, also known as Chardonnays, which are RNA-DNA hybrid guides that direct more accurate genome editing than other RNA guides. As of December 2020, the company has generated an annual revenue of USD 12,361. The company plans to develop its proprietary, next-generation CRISPR technology platform and to advance its pipeline of wholly-owned allogeneic immune cell therapies for cancers.
Who invested in Caribou Biosciences
24 investors across 3 rounds
See all investors in Caribou Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Caribou Biosciences
Who invested in Caribou Biosciences?
Caribou Biosciences has 24 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Caribou Biosciences raised?
Caribou Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Caribou Biosciences last raise money?
Caribou Biosciences's most recent round on record is a Series C, in Mar 2021.
What does Caribou Biosciences do?
Based in California, US, Caribou Biosciences Inc.
Where is Caribou Biosciences headquartered?
Caribou Biosciences is headquartered in Berkeley, US.
Which VCs invest in companies like Caribou Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Caribou Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Caribou Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.